by Simona Gilman | Jul 20, 2020 | News
Precision Oncology News reporter discusses Gemini and its prospective impact on multiple myeloma. Read more here.
by Simona Gilman | Jul 17, 2020 | News
Myeloma Research News covers GNS launch of Gemini. Read more here.
by Simona Gilman | Jul 8, 2020 | News
This is the first AI-based virtual patient for multiple myeloma, said Colin Hill, the Cambridge, Mass.-based company’s co-founder and chief executive. It is traditionally difficult to predict how specific drugs or combinations of drugs might help individual multiple...
by wpengine | Jan 8, 2020 | Featured Posts, News
Peggy Maguire, president of Cambia Health Foundation, shares how Cambia worked with GNS to use predictive analytics and identify members of Cambia’s Medicare Advantage population that could benefit from an extra layer of support. Read the full article...
by Simona Gilman | Jan 6, 2020 | News, Uncategorized
“The company Hill runs, GNS Healthcare, found a genetic signature in some multiple myeloma patients that suggested they would benefit from a transplant. For others, the risky, painful, and expensive procedure would probably only provide false hope.” Read...
by Simona Gilman | Dec 4, 2019 | News
The Milwaukee Journal Sentinel covers the results of a collaboration between the Wisconsin Business Group on Health and GNS Healthcare in identifying the impact of provider optimization on cost. Read the article!
